Agoracom Blog Home

Posts Tagged ‘Hemp’

Hollister Biosciences Inc. $HOLL.ca is Making & Donating Hand Sanitizer to Hollister, CA

Posted by AGORACOM-JC at 7:36 AM on Tuesday, March 24th, 2020
  • In the wake of the COVID-19 pandemic, Hollister is using its essential business standing and facility to source and produce hand sanitizer for its local community.
  • The CEO of Hollister Biosciences Inc, Carl Saling, shared: “The community of Hollister, CA is near and dear to our hearts, and as the first licensed cannabis company in the city of Hollister, CA, I feel that we must do whatever we can to help.

VANCOUVER, March 24, 2020 – Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT: HOB, OTC: HSTRF) (the “Company” or “Hollister“) – through its Hollister Cannabis Co division, is stepping up to manufacture and distribute a few thousand bottles of hand sanitizer to Hollister, CA.

A statewide “shelter at home” mandate has been issued for California, putting a halt to non-essential manufacturing and delay in distribution. Cannabis retailers and manufacturers are considered essential businesses in California. In the wake of the COVID-19 pandemic, Hollister is using its essential business standing and facility to source and produce hand sanitizer for its local community.

Hollister will be giving its first batch of hand sanitizer to the Hollister food bank. Multiple batches of hand sanitizer are expected to be delivered to community organizations over the next few weeks.

The CEO of Hollister Biosciences Inc, Carl Saling, shared: “The community of Hollister, CA is near and dear to our hearts, and as the first licensed cannabis company in the city of Hollister, CA, I feel that we must do whatever we can to help.

It infuriated me seeing companies price gouging much needed items, such as hand sanitizer.  I am all for making money, but not at the expense of playing on people’s fears during a time of crisis. We just had to act.

We are going to focus on donating to the facilities that are often overlooked: the food bank, nursing homes, rehabilitation centers, and homeless shelters, where some of the most vulnerable are sheltering in place.

I am calling all business owners to step up in this time of crisis and do whatever you can to help your local community.”

About Hollister Biosciences Inc. 

Hollister Biosciences Inc. is a California based vertically integrated cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality California-grown cannabis and hemp products. Hollister uses a vertically integrated, high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Cannabis Co. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products. Our wholly owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker.” 

Website:  www.hollistercannabisco.com 

HOLLISTER BIOSCIENCES INC.: 

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile onwww.sedar.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/hollister-biosciences-inc-is-making–donating-hand-sanitizer-to-hollister-ca-301028647.html

NORTHBUD $NBUD.ca – Growing Preference For #Edibles Over Smoking #Cannabis Projected To Drive Global Cannabis Edibles Market Growth $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 2:25 PM on Monday, March 23rd, 2020

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. The company recently received Canadian Cultivation Licence for its Quebec Facility. Learn More.

Growing Preference For Edibles Over Smoking Cannabis Projected To Drive Global Cannabis Edibles Market Growth

  • Rising approval of recreational marijuana has surged the demand for legal cannabis
  • Thus, cannabis edibles are extensively approved in nations such as Canada, the US, Chile, Spain, Germany, Australia, and Israel

Cannabis edibles can be defined as food products that comprise cannabinoids and its spinoffs. Numerous cannabis edibles entail a considerable amount of cannabinoids that assist in decreasing anxiety and fatigue along with enhancing appetite. Also, cannabis edibles assist in improving relaxation & euphoria and are administered for recreational as well as medicinal reasons. The growing acceptance of cannabis is the key factor likely to drive the growth of the global cannabis edibles market during the forecast period.

Further, these products are deemed to be effective, safe, and have intoxicating & healing impacts of cannabis with no exposure to likely threats of cannabis smoking. Consequently, this is projected to boost the expansion of the global cannabis edibles market in the upcoming period. In addition, the rising usage of cannabis edibles in beverages, baked items, chocolates, candies, lozenges, and gummies are also anticipated to contribute to the expansion of the global cannabis edibles market. With the rising recognition of these products in the nations that are making cannabis legal for medicinal purposes, the cannabis edibles market is projected to register a substantial rate of growth during the near future.

Apart from this, the rising approval of recreational marijuana has surged the demand for legal cannabis. Thus, cannabis edibles are extensively approved in nations such as Canada, the US, Chile, Spain, Germany, Australia, and Israel. The cannabis industry has surfaced in recent times as a productive business domain with a huge prospect for market expansion and is driving the attention of several new merchants and giant financiers. This is owing to the rising social recognition of cannabis-infused edibles and recreational marijuana products around the world.

Further, this has not only elevated the revenues and sales of top firms but has also considerably contributed to the revenue of numerous governments. Also, merchants are observing a rise in the growth avenues in businesses entailing cannabis edibles like ice creams, chocolates, and brownies, thereby fueling the global of the global cannabis edibles market.

Nevertheless, several cannabis extracts utilized in the making of the cannabis edibles are inclined to confront judicial scrutiny and regulatory challenges in the coming period that might obstruct the expansion of the global cannabis edibles market. Nonetheless, the elevated usage of cannabis edibles to efficiently treat several conditions such as epilepsy, cancer, chronic pain, anorexia, arthritis, multiple sclerosis, Alzheimer’s, and nausea is anticipated to cancel out the impacts of numerous market hindrances. To cite, as announced on March 18, 2020, Clovr, a Kansas City-located cannabis manufacturing firm, has collaborated with Wana Brands, a cannabis edibles giant, to get edible products to the quickly flourishing and much-awaited Missouri market. Introduced in 2010, the Colorado brand already serves Oregon, Ohio, California, Illinois, Michigan, Arizona, Oklahoma, and now Missouri, with intentions to function in Florida and Maryland. Lately, Wana Brands also set up an international footmark, getting its items to the Canadian cannabis market via a licensing pact with Indiva Limited.   Source: https://cannabisindustrynews24.com/1491/growing-preference-for-edibles-over-smoking-cannabis-projected-to-drive-global-cannabis-edibles-market-growth/

Primo $PRMO.ca Provides Corporate Update $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 2:04 PM on Monday, March 23rd, 2020
  • Cease trade order has been lifted and as of March 5, 2020 the Company is once again trading on the CSE under the symbol: PRMO
  • The Company was not subject to any insolvency proceedings

VANCOUVER, British Columbia, March 23, 2020 — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”) is pleased to announce that it has satisfied the provisions of the information guidelines of National Policy 12-203, by filing its annual financial statements and MD&A for the year ended July 31, 2019, and therefore its cease trade order has been lifted and as of March 5, 2020 the Company is once again trading on the CSE under the symbol: PRMO.  The Company was not subject to any insolvency proceedings.

The Company also announces the appointment of Mr. Mark Bechtel as Corporate Secretary.

Mr. Bechtel is a securities lawyer with extensive experience in Canadian capital markets and exchanges. Presently Mr. Bechtel operates a law firm located in downtown Vancouver specializing in venture and emerging markets. As Corporate Secretary of Primo Mr. Bechtel will ensure that best practices for regulatory compliance are established and maintained.

The Company has also entered into a consulting agreement with Sheryl Dhillon to act as their Corporate Governance consultant.   Ms. Dhillon is a highly experienced corporate secretary with over fifteen years of experience.  She has extensive knowledge of corporate governance, as well as strong management skills and excellent corporate communications.  Ms. Dhillon acts as Corporate Secretary for several TSXV and CSE listed companies.

“The addition of Mr. Bechtel and Ms. Dhillon is a significant value-add to the Primo team.  Their cumulative experience in various disciplines will further empower the Company’s growth.  It is an exciting time for our Company.”  Comments from Mr. Andy Jagpal, CEO & President.

ON BEHALF OF THE BOARD OF DIRECTORS

“Andy Jagpal”

President and Director

For further information, please contact Zoltan, IR Representative at:

Ph:604-722-0305
Email:[email protected]

http://primoceuticals.com/
https://twitter.com/prmonutra
www.thriveCBD.org

FORWARD LOOKING STATEMENTS:

This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

No regulatory authority has approved or disapproved the information contained in this news release.

Mota Ventures $MOTA.ca Launching Immune Support CBD Line; Pure Herbal Immunity Blend Acquiring 1,838 New Customers Within a Week APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 12:13 PM on Monday, March 23rd, 2020

Mota Ventures Corp. (CSE:MOTA)(FSE:1WZ:GR)(OTC:PEMTF) (the “Company” or “Mota”) is pleased to announce that since the launch of the Pure Herbal Immunity Blend under the First Class brand on March 14th, 2020, it has had an exceptional reception, acquiring 1,838 new customers.

The all-natural Immunity Blend is made from 100% pure essential oils, including cinnamon leaf, lemon, clove bud, lime, eucalyptus globulus, rosemary, peppermint, spearmint and oregano. Due to customer demand for pure and efficacious products to support the immune system, the Company will be launching an Immune CBD oil, along with an Elderberry Gummy product on Monday, March 23rd. The new Immune CBD product contains CBD, B3, B12, Vitamin C and Zinc. Based on the success of the launch, First Class will be increasing marketing efforts throughout the US.

The Company plans to offer similar immune products in Europe through its Sativida brand, which currently retails product in various jurisdictions in Europe, including Spain, Portugal, Austria, Germany, France and the United Kingdom.

The Company anticipates the completion of the Sativida transaction in the next seven days. Further to its January 10, 2020 news release, the Company will acquire the intellectual property and trade names of Sativida from VIDA BCN LABS SL (Spain) and Sativida OU (Estonia) (collectively, “Sativida”). The Company will license both back to Sativida in exchange for a royalty associated with the gross revenues generated by Sativida.

“As our customers around the globe face challenges in their daily lives, we are working diligently to provide products to help families with natural health needs. Our supply chain is operating uninterrupted and we are quickly working to expand our immune support product line. We stand ready to continue to adapt to market changes and innovate new products to take advantage of the numerous opportunities ahead”, states Ryan Hoggan, CEO of the Company.

About Mota Ventures Corp.

Mota is seeking to become a vertically integrated global CBD brand. Its plan is to cultivate and extract CBD into high-quality value-added products from its Latin American operations and distribute it both domestically and internationally. Its existing operations in Colombia consist of a 2.5-hectare site that has optimal year-round growing conditions and access to all necessary infrastructure. Mota is looking to establish sales channels and a distribution network internationally through the acquisition of the Sativida and First Class CBD brands. Low cost production, coupled with international, direct to customer sales channels will provide the foundation for the success of Mota.

About Sativida

Sativida is a producer and online retailer of CBD and branded CBD products in various jurisdictions in Europe, including Spain and the United Kingdom. Sativida currently develops and retails a vast range of organic CBD oils and cosmetics across Europe and is currently expanding its distribution network internationally. For more information on Sativida, readers are encouraged to review their website, www.sativida.es.

ON BEHALF OF THE BOARD OF DIRECTORS

MOTA VENTURES CORP.
Ryan Hoggan
Chief Executive Officer

For further information, readers are encouraged to contact the President of the Company, Joel Shacker, at +604.423.4733 or by email at [email protected]or www.motaventuresco.com

INTERVIEW: Empower $CBDT.ca #CBD Clinics Designated Essential Service – February Visits Climb 800% $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 4:12 PM on Thursday, March 19th, 2020

With 165,000 patients, Empower Clinics (CBDT:CSE) (EPWCF:OTCQB) has a database that almost every medical cannabis and CBD company would kill for.  Patient visits increased 351% in Q4 and 800% in February.  But would Coronavirus social gathering imitations put the clinic network at risk?

No.  In fact, it has had the opposite effect, with the clinics being designated an essential service.  Moreover, Empower has had to actually increase operating hours.

Watch this interview with the Company’s CEO, Steven McAuley, who is Six Sigma certified under the quality initiative of legendary GE chairman Jack Welch. We’ve never seen a Six Sigma certified CEO in the Canadian small cap markets. Never …. which also explains how McAuley has been able to guide Empower Clinics through the most disruptive retail environment in recent history.  

Grab your favourite beverage and settle in to watch what may be your next great small cap investment.

CLIENT FEATURE: Mota Ventures Announces 832% Growth in February 2020 over the Same Period Last Year $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 12:51 PM on Thursday, March 19th, 2020
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564664/hub/MOTA_Large.png

RECENT HIGHLIGHTS

  • First Class CBD brand achieved sales of Cdn$2,981,000 February 2020
  • Marketing efforts improved gross margins by 4.9% from January 2020 to February 2020.
  • February 2020 represents an increase of 832% over the same period last year.
  • Plans to continue growth of First Class in the United States over the balance of 2020, as well as an expansion into the European market.
  • Formalized Joint Venture With Bevcanna Enterprises: Read More
    • Will share equal ownership in the Joint Venture and will be jointly responsible for developing and funding its operations
    • Company will provide manufacturing, marketing and distribution infrastructure in the European market.
    • Parties have determined an initial product launch and will provide further details on specific regions and timing once finalize
  • Announced Collaboration for Sativida US Expansion Read More 
    • Unified Funding will provide assistance to Sativida with product sourcing, packaging, shipping, payment infrastructure and marketing
    • Sativida has become the number one search-ranked online retailer of CBD products in Spain and Mexico
  • Entered into Licensing Agreement with Phenome One Read More
    • A privately held full-service live genetic and seed preservation cannabis company.
    • Mota will have full access to Canada’s largest live genetic cannabis library with over 350 cultivars
    • Mota will have the right to propagate, cultivate, harvest and process a minimum of 10 selected cultivars

2 World Class Brands:

#1. FIRST CLASS CBD: ONE OF THE LARGEST US BASED ONLINE RETAILERS OF CBD PRODUCTS

HIGHLIGHTS:

  • Leader in online CBD sales in North America
  • Crop to package model: US grown CBD hemp
  • Acquired at a 1.5 times revenue valuation
  • Current customer base 142,000 customers -with additional leads of over 424,000 potential new customers
  • 2019 Sales of $19.2M USD/ EBITDA of 2.7M USD

  #2. SATIVIDA: ONLINE DIRECT TO CONSUMER RETAILER OF A VAST RANGE OF ORGANICE CBD OILS AND COSMETICS

HIGHLIGHTS:

  • Current distributor of CBD products in Spain, Portugal, Austria, Germany, France and the United Kingdom
  • Number one search-ranked online retailer in Spain and Mexico
  • Award winning product line known for its minimal heavy metal content and accurate CBD levels
  • 100% organic products

About Mota Ventures Corp.

Mota Ventures is seeking to become a vertically integrated global CBD brand. Its plan is to cultivate and extract CBD into high-quality value added products from its Latin American operations and distribute it both domestically and internationally. Mota has established distribution networks through the acquisition of First Class CBD in the United States and Sativida in Europe. Mota Ventures is also seeking to acquire revenue producing CBD brands and operations in both Europe and North America, with the goal of establishing an international distribution network for CBD products. Low cost production, coupled with international, direct to customer, sales channels will provide the foundation for the success of Mota Ventures.

Hub on Agoracom

FULL DISCLOSURE: Mota Ventures. is an advertising client of AGORA Internet Relations Corp.

Empower Clinics $CBDT.ca Daily Patient Count Continues at Record Pace with Medical Cannabis Certifications Deemed an Essential Service $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 7:24 AM on Thursday, March 19th, 2020

Empower Clinics adapts operational processes to manage continued record patient counts during COVID-19 outbreak

  • Patient visits in corporate clinics continue at record pace, with patients demonstrating an even greater need for plant-based medicine, as the impact of COVID-19 becomes more pervasive
  • State’s of Arizona and Oregon have declared a State of Emergency over the novel coronavirus outbreak therefore, as a medical service provider, Empowers corporate medical clinics are considered an essential service and are not subject to certain mandated closures

VANCOUVER, BC / March 18, 2020 / EMPOWER CLINICS INC. (CSE: CBDT) (OTC: EPWCF) (Frankfurt 8EC) (“Empower” or the “Company“), a vertically integrated and growth-oriented life sciences company, announces that patient visits in corporate clinics continue at record pace, with patients demonstrating an even greater need for plant-based medicine, as the impact of COVID-19 becomes more pervasive.

“The coronavirus crisis is impacting all aspects of our lives, but our clinics remain incredibly busy, as patients show how important their medical cannabis treatment options are to manage increased levels of anxiety, stress, chronic pain and PTSD” said Steven McAuley, Chairman & CEO of Empower. “We had to quickly adapt clinic operating procedures to ensure optimum safety for employees and patients, updated cleaning and sanitation protocols, and provided extensive new communications to our team and patients.”

The State’s of Arizona and Oregon have declared a State of Emergency over the novel coronavirus outbreak therefore, as a medical service provider, Empowers corporate medical clinics are considered an essential service and are not subject to certain mandated closures.

The Company has made changes to clinic operations and patient management based on the most recent recommendations from the (CDC) Centers for Disease Control and Prevention, and their guidance for healthcare facilities.

https://www.cdc.gov/coronavirus/2019-ncov/healthcare-facilities/guidance-hcf.html
https://www.cdc.gov/coronavirus/2019-ncov/healthcare-facilities/index.html

ABOUT EMPOWER

Empower is a vertically-integrated health & wellness brand with it’s first hemp-derived CBD extraction facility under development, the Company produces its proprietary line of cannabidiol (CBD) based products and distributes products through company owned and franchised clinics, with wholesale partnerships, online channels and with new retail opportunities nationwide in the U.S. The company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The company has commenced activity on how to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors: Steven McAuley

CEO

[email protected]

604-789-2146

Investors: Dustin Klein

SVP, Business Development

[email protected]

720-352-1398

For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release.Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

Mota Ventures $MOTA.ca Announces Successful Launch of New “Immune Support” Product $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM-JC at 5:23 PM on Wednesday, March 18th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/Mota-Square-Logo-For-Blog.jpg
  • First Class CBD has launched a new “immune support” product that has generated significant demand since it was released
  • This is the first of a number of new CBD products aimed at promoting personal immune health that First Class is developing
  • During the first four days, company acquired over 1,000 customers and will be scaling rapidly

VANCOUVER, BC / March 18, 2020 / Mota Ventures Corp. (CSE:MOTA)(FSE:1WZ1)(OTC:PEMTF) (the “Company“) announces that First Class CBD has launched a new “immune support” product that has generated significant demand since it was released. This is the first of a number of new CBD products aimed at promoting personal immune health that First Class is developing.

One of our primary competitive advantages as a business is our ability to adapt to market changes. With the immense demand in the market for products to promote personal immune system health, we launched a First Class immune product; during the first four days, we acquired over 1,000 customers and will be scaling rapidly. Next week we will be launching a complete line of immunity products, including a CBD oil plus B-vitamins, Vitamin C and Zinc.

Our mission is to provide pure and efficacious products to our customers that depend upon us throughout the United States and Europe. Our supply chain is functioning uninterrupted. The Company has personally met with suppliers in the United States and are confident in its ability to continue to meet the demands of the current sales volume, and new product lines for March 2020 and beyond.

“I am extremely pleased with the success of our launch of our new product line. Our ability to adapt and innovate is stronger than ever. Demand for our new immune category has been exceptional and I believe this will be a significant driver to revenue in 2020,” stated Ryan Hoggan, CEO of the Company.

About Mota Ventures Corp.

Mota is seeking to become a vertically integrated global CBD brand. Its plan is to cultivate and extract CBD into high-quality value-added products from its Latin American operations and distribute it both domestically and internationally. Its existing operations in Colombia consist of a 2.5-hectare site that has optimal year-round growing conditions and access to all necessary infrastructure. Mota is looking to establish sales channels and a distribution network internationally through the acquisition of the Sativida and First Class CBD brands. Low cost production, coupled with international, direct to customer sales channels will provide the foundation for the success of Mota.

ON BEHALF OF THE BOARD OF DIRECTORS

MOTA VENTURES CORP.
Ryan Hoggan
Chief Executive Officer

For further information, readers are encouraged to contact the President of the Company, Joel Shacker, at +604.423.4733 or by email at [email protected] or www.motaventuresco.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.

Cautionary Note Regarding Forward-Looking Statement

All statements in this press release, other than statements of historical fact, are “forward-looking information” with respect to the Company within the meaning of applicable securities laws, including with respect to the business prospects of First Class CBD and its new product lines, its plans to become a vertically integrated global CBD brand, its plans to cultivate and extract cannabis to produce CBD and high-quality value added CBD products in Latin America for distribution domestically and internationally. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Company’s public filings under the Company’s SEDAR profile at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.

SOURCE: Mota Ventures Corp.

Spyder #Cannabis $SPDR.ca – #COVID19 restrictions sparking a run on cannabis stores $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 3:43 PM on Tuesday, March 17th, 2020

SPONSOR: Spyder Cannabis (SPDR:TSXV) An established chain of high-end vape stores. Aggressive expansion plan is already in place that will focus on Canadian retail and US Hemp derived kiosks in high traffic areas. Click here for more info.

COVID-19 restrictions sparking a run on cannabis stores

By: Bruce Barcott and David Downs

  • They’re not closed yet! Customers are stocking up on cannabis this weekend, preparing for what could be more retail store restrictions in coming days.

As governors and mayors across North America order the shutdown of bars, restaurants, and gathering events, cannabis stores are experiencing a dramatic surge in sales that started over the weekend and now continues into the work week. (Leafly has an updated page tracking store closures, openings, and new delivery allowances.)

Consumers are stocking up now, eyeing their potential future over in Europe, where some nations have closed all retail outlets except food stores and pharmacies.

Cannabis and coronavirus: Here’s what you need to know

On Saturday, Boston’s WGBH broadcast images of customers lining up outside New England Treatment Access (NETA) in Brookline, one of the few licensed cannabis stores operating in Massachusetts. WGBH’s Tori Bedford reported:

In Brookline, marijuana dispensary New England Treatment Access has eliminated all walk-in orders due to a high volume of customers, and will now only serve customers who place orders in advance. “In light of the current environment, we will remain open,” an announcement on the NETA website reads, “but will move to Reserve Ahead only starting on Saturday.”

Inside the Brookline store, employees wear latex gloves, and bottles of hand sanitizer and disinfectant spray sit beside each checkout station. The process is efficient, a quick in-and-out, as compared to the massive lines seen snaking around the parking lot of the shop in the past few days, according to NETA employees.

Later Sunday, Boston Mayor Mary Walsh imposed new restrictions on the city’s bars and restaurants. Those establishments will have to cut their capacity in half, and close by 11pm every night. As of now, there are no unusual restrictions on cannabis stores.

Also Sunday, the governors of Ohio and Illinois ordered all bars and restaurants closed. By mid-day Monday, similar orders had been issued in too many states to mention.

Source: https://www.leafly.com/news/author/bruce-barcott-and-david-downs

NORTHBUD $NBUD.ca – Amid #coronavirus, Canadian #cannabis stores see ‘unprecedented’ sales surge $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 1:40 PM on Tuesday, March 17th, 2020

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. The company recently received Canadian Cultivation Licence for its Quebec Facility. Learn More.

Amid coronavirus, Canadian cannabis stores see ‘unprecedented’ sales surge

By Matt Lamers

  • Cannabis stores in Ontario and Alberta reported “unprecedented demand” as the country hunkers down to fight a worsening coronavirus outbreak, industry sources say

Executives told Marijuana Business Daily there is no threat to supply chains at this time, and safety measures have been put into place for employees and consumers.

Spiritleaf CEO Darren Bondar said his 46 stores “experienced an unprecedented demand for cannabis over the weekend with sales up 20% over the previous one and a record number of customers served.

“The supply chain remains in place, stores are stocked and we have seen an uptick in edible purchases.”

Spiritleaf is encouraging online ordering via click-and-collect programs in British Columbia, Alberta and Ontario.

In most of Canada, provinces retain monopolies over cannabis e-commerce with delivery. The click-and-collect program allows privately owned stores to take payment online so customers can pick up their orders in stores.

Ontario up 80%

Sales surged week-over-week at Ontario’s monopoly online cannabis store, but some of that increased demand is attributable to lower prices.

The government-owned store aggressively dropped prices on some products as part of an ongoing drive to improve competitiveness.

Mike Ravkine, who operates the popular price-tracking and inventory tool WhatsMyPot, recorded significant price drops at the Ontario Cannabis Store.

“The last three days have seen a marked increase in volume in sales on OCS.ca and a high demand for our same day/next day delivery option where it is available,” Daffyd Roderick, OCS communications director, wrote in an email to Marijuana Business Daily.

“Some authorized retail stores are also reporting an increase in customer volume. Saturday saw almost 3,000 orders, an 80% increase over an average Saturday.”

The OCS’ 4,000 orders Sunday represent a 100% increase from the previous week, officials told MJBizDaily.

Roderick said the OCS has sufficient inventory to meet demand.

“We are working closely with our partners and currently delivering and receiving as per our normal schedule,” he said.

Physical stores in Ontario are also seeing an increase in orders, noted Sessions Cannabis CEO Steven Fry.

“Not unlike major grocery retailers, Sessions Cannabis has seen a significant increase in sales this week due to growing concerns regarding COVID-19 social distancing protocols,” he wrote in an email.

Compared to the previous week, Fry said the Sessions on the Beach location in Toronto saw approximately:

  • A 10% more transactions per day.
  • A 10% increase in dollars spent per transaction.
  • A 21% overall sales growth.

B.C. ‘steady’

British Columbia’s online monopoly BC Cannabis Stores has not seen any new sales trends.

A spokesperson for the BC Liquor Distribution Branch (BCLDB), which operates the store as well as the province’s cannabis wholesale system, said there has been no change in sales online.

The BCLDB spokesperson also said sales on the wholesale side remain “very flat, steady.”

Alberta Cannabis, the only legal online store in the province, said it is not sharing any information.

Quebec bump

Quebec’s monopoly online store also saw increased sales.

Société québécoise du cannabis (SQDC), which is also the wholesaler for the province, said its website remains “fully functional and parcels are still being delivered.”

“Indeed, we have seen an increase in sales over the last days,” spokesman Fabrice Giguere wrote in an email to MJBizDaily.

Giguere said inventory levels, both online and in stores, are stable.

“We invite all customers returning from a trip abroad or who experience flu-like symptoms to do their shopping directly online,” he noted.

Safety first

Physical cannabis stores are taking measures to increase the health and safety of customers and employees to support social distancing.

“Sessions Cannabis is taking extra measures to ensure the safety of our customers and staff through increased cleaning and sanitation measures and we will continue to monitor the situation to ensure a safe shopping experience,” Fry said.

Bondar said Spiritleaf continues to follow all advice and government guidelines.

“All surfaces, door handles and employee stations are being sanitized throughout the workday to maintain a clean, safe environment for all of us,” he said.

“We encourage customers to check on store hours in the event that they may change to accommodate various staff members’ needs to take care of family members or who are returning from vacation and in self-isolation, which has been happening at a few locations across the country.

Source: https://mjbizdaily.com/amid-coronavirus-canadian-cannabis-stores-see-unprecedented-sales-surge/